Upon receiving ethical approval (IR.ZAUMS.REC.1399.468) from the Ethics Committee of Zahedan University of Medical Sciences, this quasi-experimental study was undertaken with 70 heart failure patients admitted to the coronary care and cardiac intensive care units of Khatam Al-Anbiah (PBUH) and Ali Ibne Abi Talib (PBUH) hospitals in 2021. Drawing from a previous study [Kamrani et al., (
12)], the sample size was determined to be 34 individuals per group, considering a 95% confidence interval and a 90% statistical power, according to the following formula. Ultimately, the sample size was set at 35 individuals per group, totaling 70 participants.
, , , , ,
Following the project's approval and after obtaining an introduction letter from the Vice-Chancellor for Research and Technology, the researcher visited the designated hospital units to brief the hospital officials on the study's objectives and research procedures. Participants were then selected through convenience sampling based on the inclusion criteria from among those patients who were willing to participate and had signed an informed consent form. The selected patients were randomly allocated to the control and intervention groups using blue and red cards, which indicated each patient's group assignment.
The inclusion criteria for this study were a physician-diagnosed heart failure, at least 24 hours post-admission, an age range of 30 to 75 years, absence of speech, hearing, and visual impairments, basic literacy, an ejection fraction (EF) of 15 to 40% as determined by ECG results, no history of mental disorders, and neither the patient nor family members being employed in the medical profession. The exclusion criteria included failure to participate in more than one training session and failure to receive the training content. Data were gathered using a demographic information questionnaire (covering age, gender, frequency of hospital admissions, smoking status, and underlying diseases) and the Treatment Adherence Scale. This scale comprises three subscales: Adherence to the dietary regimen, adherence to the activity pattern, and adherence to the medication regimen. Developed by Heydari et al. at Mashhad Nursing and Midwifery College, the scale's content validity has been confirmed. Additionally, reliability correlation coefficients for the subscales on adherence to the dietary regimen, adherence to the activity pattern, and adherence to the medication regimen were 0.86, 0.91, and 0.95, respectively (
13). In this study, the tool's reliability was verified using Cronbach’s alpha, resulting in a coefficient of 0.86. After dividing the patients into intervention and control groups, the demographic information questionnaire and the Treatment Adherence Scale were completed for all participants. Subsequently, the self-efficacy-based training intervention was implemented for the intervention group, while the control group received standard training. The training content was formulated based on authoritative sources and tailored to meet self-efficacy objectives.
The training intervention emphasized vascular risk factors, the repercussions of non-compliance, and the advantages of adhering to treatment, lifestyle modifications, medications, cessation of smoking, selection of low-fat foods, exercise, and stress management employing self-efficacy strategies. The program was delivered to heart failure patients through individual, face-to-face sessions, individual counseling, question-and-answer segments, and verbal encouragement. Starting 24 hours post-admission, the training content and self-efficacy enhancement strategies were introduced over four consecutive days in the coronary care unit. This was achieved using slides and an educational booklet prepared by the researcher in the presence of the patient and a family member. Each session lasted between 30 and 45 minutes. Prior to the intervention, an individual needs assessment was conducted for each patient to tailor the training content to their specific educational needs. The content addressed lifestyle changes (healthy nutrition, risk factor modification, symptom management, stress management) on the first day and medication administration on the second day. On the third day, participants viewed a video detailing medication types, mechanisms of action, and potential side effects like bleeding, diarrhea, rash, decreased heart rate, and blood pressure. In the final session, treatment adherence was encouraged by having patients in the intervention group maintain a diary to log their medication intake, diet, and physical activities.
The training content across all four sessions also emphasized self-efficacy enhancement strategies:
(1) Patients were provided with instructions on the essential skills and abilities needed to successfully change behavior and modify cardiovascular risk factors. Responsibilities were delegated to the patients to bolster treatment adherence, emphasizing that they are their own best caregivers through adherence to medication and dietary regimens and engagement in independent physical activity.
(2) A family member was encouraged to partake in the training, goal setting, and problem-solving to aid in achieving treatment objectives and lifestyle modifications. Patients were guided to develop an action plan for themselves with the assistance of a family member and the researcher and to share their newfound knowledge with their families. Learning skills were leveraged for behavioral change, drawing on the successful experiences of others who have managed vascular risk factors well. Patients successful in certain aspects of disease management were introduced to each other to facilitate mutual learning.
(3) The researcher fostered friendly relationships with the patients, allocating ample time to address their queries.
(4) Individual, achievable goals were established to stimulate the patients' enthusiasm and mitigate the impact of past failures in modifying risk factors.
(5) Efforts were made to ensure patients knew they could seek help when necessary and to maintain the momentum of the training provided. To this end, patients' phone numbers were collected, and they were given the researcher's contact information. The patients' daily activities and medication adherence were monitored through a diary and telephone follow-ups as part of the treatment adherence program.
(6) A family member was involved in every training session as a vital support resource. When patients successfully implemented the strategies discussed, they received encouragement, and in instances of failure, tailored training was provided as needed.
After completing the training intervention, a weekly telephone call was made to each patient in the intervention group for three months to remind them of the training instructions and to monitor their adherence to these instructions. The treatment adherence scale was administered three months post-intervention for patients in both groups. At the study's conclusion, the control group also received the training instructions, and each was given a training booklet. Data analysis was conducted using SPSS 26 software. Descriptive statistics (frequency, mean, and standard deviation) summarized the data. The chi-square test evaluated the qualitative variables' independence or dependence, and the independent samples t-test compared the contextual variables between the two groups. Additionally, the chi-square test assessed the quantitative variables. The Shapiro-Wilk test verified data normality. The significance level for this study was set at less than 0.05 (P < 0.05).